Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
12:00pm, Friday, 05'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA). Such investors are advised to conta
3 Biotech Stocks to Sell in July Before They Crash & Burn
07:30am, Friday, 05'th Jul 2024
The biotech segment is a relatively new sector that combines the fields of biology and technology. It integrates natural sciences from biology and engineering aspects from technology to develop produc
3 Biotech Stocks Turning DNA Dreams Into Dollars
06:55am, Friday, 05'th Jul 2024
When discussing biotechnology, many focus on medication based on biochemical compounds and their downstream effects. Yet several branches of medical genetics and therapeutics have begun to find novel
Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
11:05am, Wednesday, 03'rd Jul 2024
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.
Moderna Receives HHS Grant to Develop a Bird Flu Vaccine
10:41am, Tuesday, 02'nd Jul 2024
Moderna (MRNA) shares edged higher Tuesday after the biotech firm received a federal grant to develop a vaccine to prevent bird flu in humans.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA
10:00am, Tuesday, 02'nd Jul 2024
NEW YORK , July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to co
US awards Moderna $176 million to produce bird flu vaccine
07:38am, Tuesday, 02'nd Jul 2024
The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy
Moderna gets U.S. government funding for bird-flu vaccine development
07:31am, Tuesday, 02'nd Jul 2024
Moderna Inc.'s efforts to develop a bird-flu vaccine are getting a boost from the U.S. government, the company said Tuesday.
Moderna Scores Federal Funding For mRNA Bird Flu Vaccine As Pandemic Fears Grow
07:30am, Tuesday, 02'nd Jul 2024
Moderna has secured $176 million in federal funding to develop mRNA vaccines against a potential bird flu pandemic, the Boston-based company announced Tuesday, a move that could bolster U.S. vaccine s
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the developm
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case
05:51am, Tuesday, 02'nd Jul 2024
London's High Court on Tuesday ruled that one of Moderna's patents relating to technology key to the development of vaccines for COVID-19 was invalid, but that another was valid and had been infringed
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
05:11am, Tuesday, 02'nd Jul 2024
If approved, the RSV vaccine will be Moderna's (MRNA) second approved product in the European Union.
Pfizer And Moderna Vaccines Not Linked To Birth Defects, Study Finds
11:00am, Monday, 01'st Jul 2024
There is no evidence of major birth defects in babies born to mothers vaccinated against COVID-19 during the first trimester of pregnancy, according to new research published in JAMA Pediatrics on Mon
Investors Who Lost Money on Moderna, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - MRNA
07:30am, Monday, 01'st Jul 2024
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Moderna, Inc. ("Moderna") (NASDAQ:MRNA) concerning possible violations of feder
CDC Narrows Age Recommendation for Use of RSV Vaccine
12:20pm, Friday, 28'th Jun 2024
The U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74 years should only get the shot if they are at high risk for severe RSV due to chronic conditions.
